These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10429863)

  • 21. Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsy.
    Bedossa P
    Liver Int; 2009 Jan; 29 Suppl 1():19-22. PubMed ID: 19207962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noninvasive measures of liver fibrosis.
    Rockey DC; Bissell DM
    Hepatology; 2006 Feb; 43(2 Suppl 1):S113-20. PubMed ID: 16447288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The non-invasive diagnosis of cirrhosis using the Fibroscan must be performed with cause-specific stiffness cut-offs.
    Nguyen-Khac E; Capron D; Braillon A; Dupas JL
    Gut; 2008 Nov; 57(11):1630; author reply 1630-1. PubMed ID: 18941012
    [No Abstract]   [Full Text] [Related]  

  • 24. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
    Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H
    Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis of cirrhosis].
    Trinchet JC; Grando-Lemaire V
    Gastroenterol Clin Biol; 2004 May; 28(5 Suppl):D121-8. PubMed ID: 15213672
    [No Abstract]   [Full Text] [Related]  

  • 26. Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C.
    Boursier J; Bacq Y; Halfon P; Leroy V; de Ledinghen V; de Muret A; Bourlière M; Sturm N; Foucher J; Oberti F; Rousselet MC; Calès P
    Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):28-38. PubMed ID: 19060630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noninvasive biochemical markers of liver fibrosis.
    Grigorescu M
    J Gastrointestin Liver Dis; 2006 Jun; 15(2):149-59. PubMed ID: 16802010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Non-invasive diagnosis of hepatic fibrosis].
    Lu LG; Zeng MD
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):210-1. PubMed ID: 16556418
    [No Abstract]   [Full Text] [Related]  

  • 29. [Liver fibrosis: pathophysiology, diagnosis and treatment].
    Pár A; Pár G
    Orv Hetil; 2005 Jan; 146(1):3-13. PubMed ID: 15715367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of liver fibrosis in clinical practice].
    Abenavoli L; Leggio L; Gasbarrini G; Addolorato G
    Recenti Prog Med; 2006 Sep; 97(9):481-5. PubMed ID: 17017301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.
    Pagadala M; Zein CO; McCullough AJ
    Clin Liver Dis; 2009 Nov; 13(4):591-606. PubMed ID: 19818307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [How to measure liver fibrosis in viral hepatitis?].
    Pariente A
    Rev Prat; 2005 Mar; 55(6):646-9. PubMed ID: 15913116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimized stepwise combination algorithms of non-invasive liver fibrosis scores including Hepascore in hepatitis C virus patients.
    Bourliere M; Penaranda G; Ouzan D; Renou C; Botta-Fridlund D; Tran A; Rosenthal E; Wartelle-Bladou C; Delasalle P; Oules V; Portal I; Castellani P; Lecomte L; Rosenthal-Allieri MA; Halfon P
    Aliment Pharmacol Ther; 2008 Aug; 28(4):458-67. PubMed ID: 18498446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. External validation of biochemical indices for noninvasive evaluation of liver fibrosis in HCV chronic hepatitis.
    Iacobellis A; Mangia A; Leandro G; Clemente R; Festa V; Attino V; Ricciardi R; Giacobbe A; Facciorusso D; Andriulli A
    Am J Gastroenterol; 2005 Apr; 100(4):868-73. PubMed ID: 15784034
    [No Abstract]   [Full Text] [Related]  

  • 35. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.
    Leroy V; Hilleret MN; Sturm N; Trocme C; Renversez JC; Faure P; Morel F; Zarski JP
    J Hepatol; 2007 May; 46(5):775-82. PubMed ID: 17321634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Nodular hepatocellular lesions. Guidelines and minimal diagnostic criteria for gastrointestinal histopathological diagnosis. Gruppo Italiano Patologi dell'Apparato Digerente].
    Roncalli M; David E; Gentile A; Pollice L
    Pathologica; 2000 Jun; 92(3):210-20. PubMed ID: 10902435
    [No Abstract]   [Full Text] [Related]  

  • 37. Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation.
    Poynard T; Halfon P; Castera L; Charlotte F; Le Bail B; Munteanu M; Messous D; Ratziu V; Benhamou Y; Bourlière M; De Ledinghen V;
    Aliment Pharmacol Ther; 2007 Mar; 25(6):733-9. PubMed ID: 17311607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementing non-invasive markers for liver fibrosis in clinical practice.
    Sebastiani G; Alberti A
    J Hepatol; 2008 May; 48(5):880-1; author reply 881-3. PubMed ID: 18314216
    [No Abstract]   [Full Text] [Related]  

  • 39. FIBROSpect II: a potential noninvasive test to assess hepatic fibrosis.
    Poordad FF
    Expert Rev Mol Diagn; 2004 Sep; 4(5):593-7. PubMed ID: 15347253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laparoscopy and guided liver biopsy in the diagnosis of cirrhosis: conventional technique vs. minilaparoscopy.
    Orlando R; Lirussi F
    Endoscopy; 2003 Dec; 35(12):1079-80; author reply 1080. PubMed ID: 14648425
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.